Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥277.1bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥586.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥289.7bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥20.1bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥31.6bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥20.4bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥62.3bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥30.7bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥26.2bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥41.8bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥18.8bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥49.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥32.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥19.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥32.6bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥848.9bnat 2025-09-30Cons.Assets
Total assets¥813.8bnat 2025-03-31Cons.Assets
Total assets¥827.8bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥454.7bnat 2025-09-30Cons.Liabilities
Total liabilities¥438.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥394.2bnat 2025-09-30Cons.Net assets
Net assets / equity¥375.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥392.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥64.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥65.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥64.4bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥64.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥68.4bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥32.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥93.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥50.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥26.5bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥47.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥29.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥7.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥48.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥24.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥70.92025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.442024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥116.182024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio44.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 65
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥9.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥2.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2025-09-30¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥400m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥13.4bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥13.4bn
Engineering Plasticsreportable segmentrevenue2025-04-01 → 2025-09-30¥122.0bn
Engineering Plasticsreportable segmentrevenue external2025-04-01 → 2025-09-30¥121.9bn
Engineering Plasticsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥106m
Engineering Plasticsreportable segmentsegment profit2025-04-01 → 2025-09-30¥11.5bn
Materialsreportable segmentrevenue2025-04-01 → 2025-09-30¥83.1bn
Materialsreportable segmentrevenue external2025-04-01 → 2025-09-30¥77.2bn
Materialsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥5.9bn
Materialsreportable segmentsegment profit2025-04-01 → 2025-09-30¥5.0bn
Medical Healthcarereportable segmentrevenue2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentrevenue external2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentsegment profit2025-04-01 → 2025-09-30¥208m
Safetyreportable segmentrevenue2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentrevenue external2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.7bn
Smartreportable segmentrevenue2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue external2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥67m
Smartreportable segmentsegment profit2025-04-01 → 2025-09-30¥404m
—segment totalrevenue2025-04-01 → 2025-09-30¥280.7bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥274.6bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥6.1bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥19.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥290.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥277.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥7.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥344m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥13.8bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥13.8bn
Engineering Plasticsreportable segmentrevenue2024-04-01 → 2024-09-30¥124.6bn
Engineering Plasticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥124.5bn
Engineering Plasticsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥96m
Engineering Plasticsreportable segmentsegment profit2024-04-01 → 2024-09-30¥15.2bn
Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥95.1bn
Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥88.5bn
Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6.6bn
Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥14.3bn
Medical Healthcarereportable segmentrevenue2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue external2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥0
Medical Healthcarereportable segmentsegment profit2024-04-01 → 2024-09-30¥189m
Safetyreportable segmentrevenue2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentrevenue external2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.3bn
Smartreportable segmentrevenue2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue external2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥51m
Smartreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
—segment totalrevenue2024-04-01 → 2024-09-30¥293.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥286.9bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥6.7bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥31.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥303.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥289.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥13.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥31.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 588
ItemContextValueUnit
Net cash provided by used in investment activitiesPrior1InterimDuration-29391000000JPY
Net cash provided by used in investment activitiesInterimDuration-26530000000JPY
Net increase decrease in short term loans payable fin cfPrior1InterimDuration-6907000000JPY
Net increase decrease in short term loans payable fin cfInterimDuration-14256000000JPY
Net increase decrease in short term bonds payable fin cfPrior1InterimDuration-14000000000JPY
Net increase decrease in short term bonds payable fin cfInterimDuration-0JPY
Proceeds from long term loans payable fin cfPrior1InterimDuration22137000000JPY
Proceeds from long term loans payable fin cfInterimDuration22856000000JPY
Repayment of long term loans payable fin cfPrior1InterimDuration-6888000000JPY
Repayment of long term loans payable fin cfInterimDuration-6468000000JPY
Redemption of bonds fin cfPrior1InterimDuration-10000000000JPY
Redemption of bonds fin cfInterimDuration-JPY
Cash dividends paid fin cfPrior1InterimDuration-6894000000JPY
Cash dividends paid fin cfInterimDuration-7950000000JPY
Dividends paid to non controlling interests fin cfPrior1InterimDuration-765000000JPY
Dividends paid to non controlling interests fin cfInterimDuration-1238000000JPY
Repayments of lease obligations fin cfPrior1InterimDuration-725000000JPY
Repayments of lease obligations fin cfInterimDuration-778000000JPY
Other net fin cfPrior1InterimDuration-0JPY
Other net fin cfInterimDuration-0JPY
Net cash provided by used in financing activitiesPrior1InterimDuration-24043000000JPY
Net cash provided by used in financing activitiesInterimDuration-7835000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1InterimDuration-1279000000JPY
Effect of exchange rate change on cash and cash equivalentsInterimDuration1263000000JPY
Net increase decrease in cash and cash equivalentsPrior1InterimDuration-3968000000JPY
Net increase decrease in cash and cash equivalentsInterimDuration-347000000JPY
Cash and cash equivalentsPrior2YearInstant68408000000JPY
Cash and cash equivalentsPrior1YearInstant64767000000JPY
Cash and cash equivalentsPrior1InterimInstant64440000000JPY
Cash and cash equivalentsInterimInstant64419000000JPY
Merchandise and finished goodsPrior1YearInstant90075000000JPY
Merchandise and finished goodsInterimInstant99173000000JPY
Work in processPrior1YearInstant25547000000JPY
Work in processInterimInstant25152000000JPY
Raw materials and suppliesPrior1YearInstant62256000000JPY
Raw materials and suppliesInterimInstant61638000000JPY
Sales related expenses sgaPrior1InterimDuration11300000000JPY
Sales related expenses sgaInterimDuration10610000000JPY
Employees salaries and allowances sgaPrior1InterimDuration11737000000JPY
Employees salaries and allowances sgaInterimDuration12150000000JPY
Retirement benefit expenses sgaPrior1InterimDuration85000000JPY
Retirement benefit expenses sgaInterimDuration249000000JPY
Technical research expenses sgaPrior1InterimDuration12776000000JPY
Technical research expenses sgaInterimDuration12728000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E00818-000MedicalHealthcareReportableSegmentMember7185000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E00818-000SmartReportableSegmentMember19596000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E00818-000SafetyReportableSegmentMember47067000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E00818-000MaterialsReportableSegmentMember88464000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E00818-000EngineeringPlasticsReportableSegmentMember124547000000JPY
Revenues from external customersPrior1InterimDuration_ReportableSegmentsMember286862000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass